GO:0140010 D-aspartate transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140010 D-aspartate transmembrane transporter activity is a molecular function that enables the transfer of D-aspartate across a membrane.
• D-aspartate is a D-enantiomer of aspartate that can act as an endogenous agonist at NMDA receptors, and its transmembrane transport is therefore tightly linked to glutamatergic signalling.
• NMDA receptors are ligand-gated ion channels that mediate slow excitatory synaptic transmission and are activated by co-agonists including D-serine and glycine, with D-aspartate also acting as an agonist.
• The subunit composition of NMDA receptors, including GluN1, GluN2A-D and GluN3 subunits, determines their biophysical properties, trafficking and pharmacology.
• Dysregulation of D-aspartate transport and NMDA receptor function has been implicated in neurodevelopmental, psychiatric and neurodegenerative conditions.
• CRISPR-based knockout, point-mutation, knock-in and overexpression models are essential for dissecting the causal roles of transporters and receptors in D-aspartate-dependent biology.
Description
GO:0140010 D-aspartate transmembrane transporter activity is defined as the molecular function that enables the transfer of D-aspartate from one side of a membrane to the other. D-aspartate is a free D-amino acid that is present in the mammalian brain and periphery, and it can act as an agonist at NMDA receptors, which are ligand-gated ion channels that mediate excitatory synaptic transmission. Because D-aspartate must cross cellular membranes to reach its sites of action, transporters and channels that mediate its flux are central to its physiology. Understanding this activity is therefore important for researchers studying amino acid homeostasis, neurotransmitter release and receptor activation. NMDA receptors are heteromeric complexes typically composed of GluN1 and GluN2 subunits, and their activation requires binding of co-agonists such as glycine or D-serine, with D-aspartate also capable of acting as an agonist. The structural and functional properties of these receptors have been extensively characterized, including mechanisms of conductance control, neurosteroid binding and ligand gating. Because D-aspartate transport can influence the local concentration of this agonist, it is mechanistically linked to NMDA receptor signalling and downstream neuronal functions. This article summarizes the authoritative GO definition, the biological processes and molecular mechanisms associated with D-aspartate transmembrane transporter activity, the key genes and proteins involved, and the experimental models used to study it.
D-aspartate transmembrane transporter activity At A Glance
| GO ID | GO:0140010 |
|---|---|
| GO term | D-aspartate transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | None listed |
| Major function | Enables the transfer of D-aspartate from one side of a membrane to the other |
| Related molecules | NMDA receptor subunits including GluN1, GluN2A-D and GluN3, which are activated by D-aspartate and related co-agonists |
| Associated processes | Glutamatergic synaptic transmission, amino acid homeostasis and receptor-mediated signalling |
| Disease relevance | Neurodevelopmental, psychiatric and neurodegenerative conditions linked to NMDA receptor dysfunction |
What Is GO:0140010?
According to the Gene Ontology, GO:0140010 D-aspartate transmembrane transporter activity is a molecular function that enables the transfer of D-aspartate from one side of a membrane to the other. This activity is distinct from receptor binding or receptor activity because it specifically describes the movement of the D-aspartate molecule across a lipid bilayer, which may occur through dedicated transporters or through channel-mediated flux. The term is classified under the molecular_function aspect of the Gene Ontology and does not have listed synonyms in the QuickGO entry.
Why Is D-aspartate transmembrane transporter activity Important in Cell Biology?
D-aspartate transmembrane transporter activity is important because it controls the availability of D-aspartate, an endogenous agonist that can activate NMDA receptors, which are central to excitatory synaptic transmission, synaptic plasticity and neuronal development. NMDA receptors are heteromeric ligand-gated ion channels whose subunit composition and gating properties determine their physiological roles, and their dysfunction has been linked to neurological and psychiatric disorders. By regulating D-aspartate flux across membranes, this transporter activity can shape receptor activation and downstream signalling, making it a relevant target for mechanistic studies and therapeutic exploration.
• Controls the transmembrane movement of D-aspartate, an endogenous NMDA receptor agonist.
• Influences glutamatergic synaptic transmission and excitatory signalling in the brain.
• Contributes to amino acid homeostasis and neurotransmitter dynamics.
• NMDA receptor subunits such as GluN1, GluN2A-D and GluN3 determine receptor properties and are linked to D-aspartate responses.
• Dysregulation of NMDA receptor function is implicated in neurodevelopmental and psychiatric disorders.
• Provides a mechanistic entry point for studying receptor gating, conductance control and neurosteroid modulation.
• Relevant to neurodegenerative conditions where excitatory signalling is perturbed.
• Supports research on ligand-gated ion channel pharmacology and allosteric modulation.
• Enables investigation of D-amino acid biology in both brain and peripheral tissues.
• Offers a target for CRISPR-based functional genomics of transporters and receptors.
Molecular Mechanism of D-aspartate transmembrane transporter activity
Substrate recognition and binding
In simple terms: The transporter must first recognize and bind D-aspartate before moving it across the membrane.
D-aspartate transmembrane transporter activity requires specific recognition of the D-aspartate molecule, which is the D-enantiomer of aspartate and can act as an agonist at NMDA receptors. NMDA receptors are ligand-gated ion channels that bind co-agonists such as glycine and D-serine, and D-aspartate can also serve as an agonist, indicating that binding pockets in these receptors can accommodate D-amino acids. Structural studies of NMDA receptors have revealed the architecture of the ligand-binding domains and the conformational changes that occur upon agonist binding, which is relevant for understanding how D-aspartate interacts with its targets.
Conformational changes and channel gating
In simple terms: After binding, the protein changes shape to allow D-aspartate to pass through the membrane.
Ligand binding to NMDA receptors induces conformational changes that lead to channel opening, a process that has been characterized by structural and functional studies. The mechanism of conductance control and neurosteroid binding in NMDA receptors has been investigated, revealing how the channel pore and its surrounding domains regulate ion flow. Tri-heteromeric NMDA receptors such as GluN1-2B-2D exhibit distinct gating and blockade properties, which may influence the flux of D-aspartate and other permeant molecules. These gating mechanisms are essential for understanding how D-aspartate transmembrane transporter activity is coupled to receptor activation.
Ion flux and membrane transport
In simple terms: Once open, the channel or transporter allows D-aspartate to move from one side of the membrane to the other.
The transfer of D-aspartate across a membrane is the defining feature of GO:0140010, and this flux can occur through channel-mediated or transporter-mediated mechanisms. NMDA receptors are ion channels that permit the flow of cations, and their activation by agonists such as D-aspartate can lead to membrane depolarization and downstream signalling. The structural dynamics of related ionotropic glutamate receptors, such as AMPA receptors, provide comparative insights into how ligand-gated ion channels open and conduct ions. These principles help explain how D-aspartate transport is integrated with receptor-mediated ion flux.
Regulation by neurosteroids and allosteric modulators
In simple terms: Other molecules can bind to the transporter or receptor and change how much D-aspartate moves.
Neurosteroids and other allosteric modulators can influence NMDA receptor function, including conductance control and channel gating. The binding of neurosteroids to NMDA receptors has been structurally characterized, revealing sites that modulate receptor activity. Such modulation can indirectly affect D-aspartate transmembrane transporter activity by altering the open probability or conductance of the channel through which D-aspartate moves. Understanding these regulatory mechanisms is important for pharmacological targeting of D-aspartate-dependent processes.
Subunit composition and functional diversity
In simple terms: Different combinations of protein subunits create transporters or channels with different properties.
NMDA receptors are assembled from subunits including GluN1, GluN2A-D and GluN3, and the specific subunit composition determines receptor properties such as agonist sensitivity, conductance and trafficking. Assembly and architecture of endogenous NMDA receptors in adult cerebral cortex and hippocampus have been studied, showing that native receptors exist as diverse heteromeric complexes. GluD1, a related ionotropic receptor-like protein, functions as a signal transduction device rather than a conventional ion channel, illustrating the functional diversity within this protein family. These findings highlight how subunit composition can shape D-aspartate transmembrane transporter activity and its physiological consequences.
Key Genes Involved in GO:0140010 D-aspartate transmembrane transporter activity
The following genes and proteins are involved in D-aspartate transmembrane transporter activity and related NMDA receptor signalling, based on published structural, functional and trafficking studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GRIN1 | Encodes GluN1, the obligatory subunit of NMDA receptors that binds co-agonists and forms the channel pore | Essential for NMDA receptor assembly and D-aspartate-responsive signalling |
| GRIN2A | Encodes GluN2A, a subunit that confers specific gating and pharmacological properties | Determines receptor kinetics and sensitivity to agonists |
| GRIN2B | Encodes GluN2B, a subunit involved in synaptic plasticity and neurodevelopment | Target for studying developmental and psychiatric phenotypes |
| GRIN2C | Encodes GluN2C, a subunit with distinct expression and functional properties | Contributes to regional and cell-type-specific receptor diversity |
| GRIN2D | Encodes GluN2D, a subunit found in tri-heteromeric receptors | Relevant to gating and blockade mechanisms |
| GRIN3A | Encodes GluN3A, a subunit that can modulate receptor function | Influences receptor composition and signalling |
| GRIN3B | Encodes GluN3B, a subunit with roles in receptor diversity | Studied for its impact on channel properties |
| GRID1 | Encodes GluD1, a receptor-like protein that acts as a signal transduction device | Provides insight into non-canonical ionotropic receptor function |
| GRID2 | Encodes GluD2, a related orphan receptor | Comparative studies of receptor family evolution and function |
| SLC1A1 | Encodes a glutamate transporter family member | Potential contributor to D-aspartate uptake and homeostasis |
| SLC1A2 | Encodes a glial glutamate transporter | Relevant to extracellular D-aspartate clearance |
| SLC1A3 | Encodes a glutamate transporter involved in amino acid homeostasis | May influence D-aspartate availability |
| SLC7A11 | Encodes a cystine/glutamate antiporter | Linked to redox balance and amino acid transport |
| SLC25A12 | Encodes a mitochondrial aspartate/glutamate carrier | Mitochondrial aspartate handling may affect D-aspartate pools |
| GOT1 | Encodes a cytosolic aspartate aminotransferase | Contributes to aspartate metabolism and D-aspartate levels |
| GOT2 | Encodes a mitochondrial aspartate aminotransferase | Involved in aspartate and D-aspartate metabolic pathways |
| DDO | Encodes D-aspartate oxidase, which degrades D-aspartate | Regulates D-aspartate concentration and availability |
| AGXT2 | Encodes alanine-glyoxylate aminotransferase 2 | Potential role in D-amino acid metabolism |
How Is D-aspartate transmembrane transporter activity Regulated?
D-aspartate transmembrane transporter activity is regulated at multiple levels, including receptor subunit composition, allosteric modulation by neurosteroids, and trafficking of channel proteins to the membrane. NMDA receptor function is influenced by neurosteroid binding, which can alter conductance and gating properties. The assembly of endogenous NMDA receptors in adult cortex and hippocampus involves specific subunit combinations that determine their regulatory properties. Trafficking of TRP channels and related membrane proteins provides a general framework for understanding how transporter and channel abundance at the cell surface is controlled. Additionally, ligand gating and opening mechanisms of NMDA receptors are subject to modulation by agonists and allosteric factors, which can indirectly regulate D-aspartate flux.
D-aspartate transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GRIN1 | Neurodevelopmental disorders and NMDA receptor dysfunction | Knockout and point-mutation models to study receptor assembly and gating |
| GRIN2A | Epilepsy and neurodevelopmental phenotypes | Knock-in models with disease-associated variants |
| GRIN2B | Psychiatric disorders and synaptic plasticity defects | Overexpression and knockout models in neurons |
| GRID1 | Neurodevelopmental signalling via GluD1 | Knockout and knock-in models to dissect signal transduction |
| DDO | D-aspartate metabolism and availability | Knockout models to assess D-aspartate levels and receptor activation |
Neurodevelopmental and psychiatric disorders
NMDA receptor dysfunction has been implicated in neurodevelopmental and psychiatric conditions, and D-aspartate transmembrane transporter activity may influence receptor activation by regulating agonist availability. Tripartite signalling by NMDA receptors involves interactions with other receptors and signalling molecules, which can contribute to disease phenotypes when dysregulated. GluD1, a receptor-like protein, functions as a signal transduction device and has been linked to neurodevelopmental processes. These findings suggest that genes involved in D-aspartate transport and NMDA receptor function are relevant to psychiatric and developmental research.
Neurodegenerative conditions
Excitatory signalling mediated by NMDA receptors is critical for neuronal survival and plasticity, and its dysregulation has been associated with neurodegenerative processes. Structural studies of NMDA receptor gating and conductance control provide a basis for understanding how altered receptor function may contribute to neurodegeneration. The architecture of endogenous NMDA receptors in adult brain regions such as cortex and hippocampus is relevant to age-related changes in receptor composition and function. Targeting D-aspartate transport and NMDA receptor activity may therefore offer therapeutic avenues for neurodegenerative conditions.
Epilepsy and excitability disorders
NMDA receptors mediate slow excitatory synaptic currents, and their excessive activation can lead to neuronal hyperexcitability. Mechanisms of channel gating and blockade in tri-heteromeric NMDA receptors have been characterized, which is relevant to understanding excitability disorders. Neurosteroid modulation of NMDA receptors can influence seizure susceptibility and neuronal excitability. Thus, D-aspartate transmembrane transporter activity may indirectly affect seizure thresholds by regulating agonist availability.
From D-aspartate transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate transporter alter D-aspartate flux? | Knockout cell lines and primary neurons |
| How do disease-associated point mutations affect channel gating? | Point-mutation knock-in models |
| Can a tagged transporter be used to track localization? | Tagged knock-in with fluorescent or affinity tags |
| Does overexpression of a receptor subunit change agonist sensitivity? | Overexpression models in heterologous cells and neurons |
| Which genes are required for D-aspartate-dependent signalling? | CRISPR library screening in neuronal cell models |
| How does subunit composition affect conductance? | Tri-heteromeric receptor expression models |
How to Study the D-aspartate transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Ion channel conductance and gating | Assessing NMDA receptor responses to D-aspartate |
| Cryo-electron microscopy | Three-dimensional protein structure | Determining ligand-binding and gating conformations |
| Fluorescence microscopy | Protein localization and trafficking | Tracking transporter surface expression |
| Radioligand binding | Ligand-receptor interactions | Measuring agonist affinity at NMDA receptors |
| Site-directed mutagenesis | Functional impact of specific residues | Mapping gating and conductance determinants |
| CRISPR knockout screening | Gene requirement in cellular phenotypes | Identifying genes needed for D-aspartate responses |
| Transcriptomics | Gene expression changes | Profiling receptor subunit expression across brain regions |
| Proteomics | Protein abundance and interactions | Characterizing native receptor complexes |
Electrophysiology
Electrophysiological recordings are used to measure ion channel activity and conductance, which are directly relevant to D-aspartate transmembrane transporter activity. Patch-clamp studies of NMDA receptors have revealed mechanisms of ligand gating, conductance control and blockade. These methods allow researchers to assess how D-aspartate and other agonists affect channel opening and ion flux.
Structural biology
Cryo-electron microscopy and X-ray crystallography have been used to determine the structures of NMDA receptors and related ionotropic glutamate receptors. These studies provide atomic-level insights into ligand binding, conformational changes and channel gating. Structural analysis of endogenous NMDA receptors in adult brain tissue has revealed the architecture of native receptor complexes.
Fluorescence imaging and trafficking assays
Fluorescence imaging is used to study the localization and trafficking of membrane proteins, including channels and transporters. Tagged receptors can be visualized in live cells to monitor surface expression and internalization. These approaches help determine how D-aspartate transporters and channels are delivered to the membrane.
Biochemical and pharmacological assays
Biochemical assays measure ligand binding, receptor activation and downstream signalling. Pharmacological tools such as agonists, antagonists and neurosteroids are used to probe NMDA receptor function. These methods are essential for linking D-aspartate transport to receptor-mediated cellular responses.
How CRISPR Can Be Used to Study GO:0140010 D-aspartate transmembrane transporter activity
Knockout
CRISPR knockout models are used to eliminate candidate genes involved in D-aspartate transmembrane transporter activity, such as NMDA receptor subunits or transporters. Knockout cell lines and neurons can reveal whether a specific gene is required for D-aspartate flux or receptor-mediated signalling. These models are foundational for establishing causal roles in cellular and physiological assays.
Point Mutation
Point-mutation models introduce specific amino acid changes to study the functional consequences of disease-associated variants or key residues in transporters and channels. For example, mutations in the ligand-binding domain or pore region of NMDA receptors can alter gating and conductance. These models are valuable for dissecting structure-function relationships relevant to D-aspartate transport.
Knock-in
Knock-in models allow the introduction of tagged or reporter versions of genes to track protein localization and dynamics. Tagged NMDA receptor subunits can be used to study assembly, trafficking and surface expression in native contexts. Knock-in of disease variants can also model human genetic conditions in animal or cellular systems.
Overexpression
Overexpression models increase the levels of specific transporters or receptor subunits to study their effects on D-aspartate-dependent signalling. Overexpression of NMDA receptor subunits in heterologous cells or neurons can enhance or alter receptor function. These models help determine whether increased transporter or channel activity is sufficient to change cellular responses.
How EDITGENE Supports D-aspartate transmembrane transporter activity Research
Researchers studying D-aspartate transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in D-aspartate flux, receptor activation or downstream neuronal signalling. EDITGENE provides CRISPR-based cell model services that enable precise genetic manipulation of these targets, from complete knockout to subtle point mutations and tagged knock-ins.
Contact EDITGENE today to design your custom CRISPR model for D-aspartate transmembrane transporter activity research.
Frequently Asked Questions About D-aspartate transmembrane transporter activity
What is D-aspartate transmembrane transporter activity?
It is a Gene Ontology molecular function (GO:0140010) that enables the transfer of D-aspartate from one side of a membrane to the other.
What genes are involved in D-aspartate transmembrane transporter activity?
Genes encoding NMDA receptor subunits such as GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A and GRIN3B, as well as transporters like SLC1A1 and SLC1A2, are relevant to D-aspartate transport and signalling.
How is D-aspartate related to NMDA receptors?
D-aspartate can act as an agonist at NMDA receptors, which are ligand-gated ion channels that mediate excitatory synaptic transmission.
What is the GO ID for D-aspartate transmembrane transporter activity?
The GO ID is GO:0140010, classified under the molecular_function aspect.
Which diseases are linked to D-aspartate transport and NMDA receptors?
Neurodevelopmental, psychiatric and neurodegenerative conditions have been associated with NMDA receptor dysfunction.
What experimental models are used to study D-aspartate transmembrane transporter activity?
Knockout, point-mutation, knock-in and overexpression cell and animal models, combined with electrophysiology and structural biology, are commonly used.
How does subunit composition affect NMDA receptor function?
Different combinations of GluN1, GluN2 and GluN3 subunits determine receptor gating, conductance and pharmacology.
Can CRISPR be used to study D-aspartate transporters?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models enable precise functional dissection of genes involved in D-aspartate transport.
What is the role of neurosteroids in NMDA receptor function?
Neurosteroids can bind to NMDA receptors and modulate conductance and gating, indirectly affecting D-aspartate flux.
What methods measure D-aspartate transmembrane transport?
Patch-clamp electrophysiology, structural biology, fluorescence imaging and biochemical assays are used to measure transport and receptor activity.
Conclusion
GO:0140010 D-aspartate transmembrane transporter activity defines a molecular function essential for moving D-aspartate across membranes, with direct implications for NMDA receptor activation and glutamatergic signalling. The genes encoding NMDA receptor subunits and related transporters are central to this activity, and their dysfunction has been linked to neurodevelopmental, psychiatric and neurodegenerative conditions. Advances in structural biology, electrophysiology and CRISPR-based models continue to clarify the mechanisms and regulatory pathways involved. Researchers can leverage these tools to dissect the causal roles of specific genes in D-aspartate-dependent biology.
References
- 1. Kang H et al.. 2025. Mechanism of conductance control and neurosteroid binding in NMDA receptors.. Nature 648(8092):220-228 PMID: 41162707
- 2. Zhang M et al.. 2025. Assembly and architecture of endogenous NMDA receptors in adult cerebral cortex and hippocampus.. Cell 188(5):1198-1207.e13 PMID: 39855198
- 3. Rajani V et al.. 2020. Tripartite signalling by NMDA receptors.. Mol Brain 13(1):23 PMID: 32070387
- 4. Dai J et al.. 2021. GluD1 is a signal transduction device disguised as an ionotropic receptor.. Nature 595(7866):261-265 PMID: 34135511
- 5. Chou TH et al.. 2024. Molecular mechanism of ligand gating and opening of NMDA receptor.. Nature 632(8023):209-217 PMID: 39085540
- 6. Liedtke WB et al.. 2007. TRP Channel Trafficking.. PMID: 21204515
- 7. Kang H et al.. 2025. Structural basis for channel gating and blockade in tri-heteromeric GluN1-2B-2D NMDA receptor.. Neuron 113(7):991-1005.e5 PMID: 39954679
- 8. Gonzalez CU et al.. 2024. Structural dynamics in α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor gating.. Curr Opin Struct Biol 87:102833 PMID: 38733862
